FDA Import Refusal 799-6977259-7/41/1 — Aventis Pharma Limited
The FDA refused shipment 799-6977259-7/41/1 from Aventis Pharma Limited (United Kingdom) on May 29, 2020. The refused product falls under Drugs and Biologics — HYDROXYCHLOROQUINE SULFATE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- May 29, 2020
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 62LAC29 HYDROXYCHLOROQUINE SULFATE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL)
- Charges
- 75